This review considers antiviral nucleoside analog (NA) drugs, including ribavirin, favipiravir,
and molnupiravir, which induce genome error catastrophe in SARS‐CoV or SARS‐CoV‐2 …

Chikungunya virus (CHIKV) is a re-emerging mosquito-borne virus that displays a large cell
and organ tropism, and causes a broad range of clinical symptoms in humans. It is …

The ongoing coronavirus disease 2019 pandemic has forced the clinical and scientific
community to try drug repurposing of existing antiviral agents as a quick option against …

In recent decades, chikungunya virus (CHIKV) has re-emerged, leading to outbreaks of
chikungunya fever in Africa, Asia and Central and South America. The disease is …

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has re-emerged in
recent decades, causing large-scale epidemics in many parts of the world. CHIKV infection …

Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public
health. It is a member of the Togaviridae family and alphavirus genus and causes an …

Antiviral drugs (AvDs) are the primary resource in the global battle against viruses, including
the recent fight against corona virus disease 2019 (COVID-19). Most AvDs require multiple …

Chikungunya virus (CHIKV) is the causative agent of chikungunya fever (CHIKF) and is
categorized as a (n)(re) emerging arbovirus. CHIKV has repeatedly been responsible for …

Chikungunya (CHIK) is a reemerging arboviral disease caused by chikungunya virus
(CHIKV) infection. The disease is clinically hallmarked by prolonged debilitating joint pain …

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has spread to more
than 60 countries worldwide. CHIKV infection leads to a febrile illness known as …